PATENT CLAIM ANALYSIS

Application Number: 16037150
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["435", "007320"]

Abstract:
The present invention concerns a composition comprising at least three peptides derived from  Mycobacterium tuberculosis  antigen Rv2626c, its use in the diagnostic of latently infected  Mycobacterium tuberculosis  (LTBI) subjects, corresponding methods of use and kits.

Claim (Index 16):
A kit for diagnosing LTBI subjects and/or for discriminating healthy subjects, subjects with active  Tuberculosis  and LTBI subjects comprising:\n (i) a composition as claimed in  claim 1 ; and (ii) instructions for use to diagnose LTBI and/or for discriminating healthy subjects, subjects with active  Tuberculosis  and LTBI subjects.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 95.0
- Lexical Diversity: 1.14286
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15505292', '13263442', '15104957', '13119938', '10593384']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5868022459751157
- 35 USC 102 Novelty (BERT): 0.583174553332789
- Combined Prediction Score: 0.586439476710883
- Mean Citation Score: 364.22367
- Max Citation Score: 527.5229
- Similarity Product: 389.208251852876

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test